QX
  • Services
  • Contact
  • PORTAL
    • CRISIS CENTER >
      • MEDIA
      • THOUGHTS
      • TRADE IDEAS
      • INVESTMENT IDEAS
    • RUMORS
    • PODCASTS
    • PRO
    • STANCHART SWINGS
    • HOME
    • Regular >
      • Econ Calendar
    • Premium >
      • Briefings
      • Daily Market Strategy
      • DMS Calendar
      • THOUGHTS
      • THECHOSEN
      • VIRTU Alerts
    • EDUCATION >
      • SCALPER SYSTEM >
        • SCALPER CLASS
        • SAMPLES
      • MENTOR GUIDE
      • MENTORSHIP
      • GAV JOURNAL
      • JOURNAL
      • KEEL SWINGS
      • DAY & SWING SYSTEMS HQ
      • FULL SYSTEM EDUCATION
    • LEGAL - ToS
  • MEDIA
  • 0DTE
  • Services
  • Contact
  • PORTAL
    • CRISIS CENTER >
      • MEDIA
      • THOUGHTS
      • TRADE IDEAS
      • INVESTMENT IDEAS
    • RUMORS
    • PODCASTS
    • PRO
    • STANCHART SWINGS
    • HOME
    • Regular >
      • Econ Calendar
    • Premium >
      • Briefings
      • Daily Market Strategy
      • DMS Calendar
      • THOUGHTS
      • THECHOSEN
      • VIRTU Alerts
    • EDUCATION >
      • SCALPER SYSTEM >
        • SCALPER CLASS
        • SAMPLES
      • MENTOR GUIDE
      • MENTORSHIP
      • GAV JOURNAL
      • JOURNAL
      • KEEL SWINGS
      • DAY & SWING SYSTEMS HQ
      • FULL SYSTEM EDUCATION
    • LEGAL - ToS
  • MEDIA
  • 0DTE

US Jul 10th

7/11/2020

0 Comments

 
​The Dow notched a weekly gain thanks to a strong finish on Friday, as a record daily surge in cases was cast aside by positive reports about a potential Covid-19 vaccine.  

The Dow Jones Industrial Average added 1.44%, or 369 points. The S&P 500 rose 1.07%, while the Nasdaq Composite rose 0.66% to a close at a record high.

Gilead Sciences (NASDAQ:GILD) released data on Friday showing its antiviral drug, remdesivir, cut the risk of death for severely sick coronavirus patients by 62% compared with standard care alone, sending its shares 2.2% higher.

Biontech (NASDAQ:BNTX), up 7.2%, also delivered positive news in the race of a vaccine, with CEO Ugur Sahin reportedly claiming the company could have a treatment ready for approval by December, according to The Wall Street Journal.

The promising update on a vaccine helped ease investor jitters over the rapid spread of coronavirus, which infected a record 60,565 people in the U.S. on Thursday.

Energy and financials, both of which had been under pressure this week, jumped more than 2%, pushing the broader market higher.

The rise in financials was underpinned by a swing higher in bank stocks ahead of earnings next week.

Citigroup (NYSE:C), JPMorgan (NYSE:JPM), and Wells Fargo (NYSE:WFC), all of which are set to report their second-quarter results on Tuesday, were up more than 2%. 

Renewed action on the reopening trade - bullish bets on stocks tied to the progress of the economic reopening - also benefited airlines and cruise lines, with the latter benefiting from a surge in cruise operator Carnival (NYSE:CUK).

Carnival (NYSE:CCL) jumped 10.8% on Friday after the cruise operator said it was cutting capacity and indicated that demand for 2021 is growing.

Tech joined the rally late-on after cutting gains.

Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Alphabet (NASDAQ:GOOGL) and Amazon.com (NASDAQ:AMZN), the so-called Fab 5, making up about 40% of the Nasdaq Index, ended higher.

Elsewhere, Tesla (NASDAQ:TSLA) ended the day up 10.8% to end above $1,500 for the first time ever.
0 Comments



Leave a Reply.

EQUITIES | CURRENCIES | FUTURES | CRYPTOCURRENCIES